Product: STAT5 Mouse Monoclonal Antibody
Catalog: BF8164
Description: Mouse monoclonal antibody to STAT5
Application: WB IHC
Reactivity: Human, Rat
Prediction: Pig, Zebrafish, Bovine, Horse, Sheep, Rabbit, Dog, Xenopus
Mol.Wt.: 90kDa; 91kD,90kD(Calculated).
Uniprot: P42229 | P51692

View similar products>>

   Size Price Inventory
 100ul $280 In stock
 200ul $350 In stock

Lead Time: Same day delivery

For pricing and ordering contact:
Local distributors

Product Info

Source:
Mouse
Application:
WB 1:500-1:3000, IHC 1:50-1:200
*The optimal dilutions should be determined by the end user.
*Tips:

WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.

Reactivity:
Human,Rat
Clonality:
Monoclonal [AFfirm8164]
Specificity:
STAT5 Antibody detects endogenous levels of total STAT5.
Conjugate:
Unconjugated.
Purification:
Affinity-chromatography.
Storage:
Mouse IgG1 in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
Alias:

Fold/Unfold

Mammary gland factor; MGF; Signal transducer and activator of transcription 5A; STA5A_HUMAN; STAT 5; STAT 5A; STAT5; STAT5A; Signal transducer and activator of transcription 5B; STA5B_HUMAN; STAT5; Stat5b; Transcription factor STAT5B;

Immunogens

Immunogen:
Uniprot:
Gene(ID):
Description:
STAT5B transcription factor of the STAT family. Phosphorylated and activated by receptor-associated kinases triggered by cytokines including IL2, IL3, GM-CSF, and various growth hormones. It has been shown to be involved in diverse biological processes, such as TCR signaling, apoptosis, adult mammary gland development, and sexual dimorphism of liver gene expression.
Sequence:
MAGWIQAQQLQGDALRQMQVLYGQHFPIEVRHYLAQWIESQPWDAIDLDNPQDRAQATQLLEGLVQELQKKAEHQVGEDGFLLKIKLGHYATQLQKTYDRCPLELVRCIRHILYNEQRLVREANNCSSPAGILVDAMSQKHLQINQTFEELRLVTQDTENELKKLQQTQEYFIIQYQESLRIQAQFAQLAQLSPQERLSRETALQQKQVSLEAWLQREAQTLQQYRVELAEKHQKTLQLLRKQQTIILDDELIQWKRRQQLAGNGGPPEGSLDVLQSWCEKLAEIIWQNRQQIRRAEHLCQQLPIPGPVEEMLAEVNATITDIISALVTSTFIIEKQPPQVLKTQTKFAATVRLLVGGKLNVHMNPPQVKATIISEQQAKSLLKNENTRNECSGEILNNCCVMEYHQATGTLSAHFRNMSLKRIKRADRRGAESVTEEKFTVLFESQFSVGSNELVFQVKTLSLPVVVIVHGSQDHNATATVLWDNAFAEPGRVPFAVPDKVLWPQLCEALNMKFKAEVQSNRGLTKENLVFLAQKLFNNSSSHLEDYSGLSVSWSQFNRENLPGWNYTFWQWFDGVMEVLKKHHKPHWNDGAILGFVNKQQAHDLLINKPDGTFLLRFSDSEIGGITIAWKFDSPERNLWNLKPFTTRDFSIRSLADRLGDLSYLIYVFPDRPKDEVFSKYYTPVLAKAVDGYVKPQIKQVVPEFVNASADAGGSSATYMDQAPSPAVCPQAPYNMYPQNPDHVLDQDGEFDLDETMDVARHVEELLRRPMDSLDSRLSPPAGLFTSARGSLS

MAVWIQAQQLQGEALHQMQALYGQHFPIEVRHYLSQWIESQAWDSVDLDNPQENIKATQLLEGLVQELQKKAEHQVGEDGFLLKIKLGHYATQLQNTYDRCPMELVRCIRHILYNEQRLVREANNGSSPAGSLADAMSQKHLQINQTFEELRLVTQDTENELKKLQQTQEYFIIQYQESLRIQAQFGPLAQLSPQERLSRETALQQKQVSLEAWLQREAQTLQQYRVELAEKHQKTLQLLRKQQTIILDDELIQWKRRQQLAGNGGPPEGSLDVLQSWCEKLAEIIWQNRQQIRRAEHLCQQLPIPGPVEEMLAEVNATITDIISALVTSTFIIEKQPPQVLKTQTKFAATVRLLVGGKLNVHMNPPQVKATIISEQQAKSLLKNENTRNDYSGEILNNCCVMEYHQATGTLSAHFRNMSLKRIKRSDRRGAESVTEEKFTILFESQFSVGGNELVFQVKTLSLPVVVIVHGSQDNNATATVLWDNAFAEPGRVPFAVPDKVLWPQLCEALNMKFKAEVQSNRGLTKENLVFLAQKLFNNSSSHLEDYSGLSVSWSQFNRENLPGRNYTFWQWFDGVMEVLKKHLKPHWNDGAILGFVNKQQAHDLLINKPDGTFLLRFSDSEIGGITIAWKFDSQERMFWNLMPFTTRDFSIRSLADRLGDLNYLIYVFPDRPKDEVYSKYYTPVPCESATAKAVDGYVKPQIKQVVPEFVNASADAGGGSATYMDQAPSPAVCPQAHYNMYPQNPDSVLDTDGDFDLEDTMDVARRVEELLGRPMDSQWIPHAQS

PTMs - P42229/P51692 As Substrate

Site PTM Type Enzyme
Y22 Phosphorylation
K70 Ubiquitination
K71 Ubiquitination
K84 Acetylation
K84 Ubiquitination
K86 Ubiquitination
Y90 Phosphorylation
T92 O-Glycosylation
T92 Phosphorylation
Y114 Phosphorylation
S127 Phosphorylation
S128 Phosphorylation
K163 Ubiquitination
K164 Ubiquitination
S193 Phosphorylation
K207 Ubiquitination
K232 Ubiquitination
K235 Ubiquitination
K242 Ubiquitination
T245 Phosphorylation
K256 Sumoylation
K256 Ubiquitination
K336 Sumoylation
K343 Ubiquitination
K359 Ubiquitination
K370 Ubiquitination
T372 Phosphorylation
S375 Phosphorylation
K380 Ubiquitination
K384 Acetylation
K384 Sumoylation
K384 Ubiquitination
S473 Phosphorylation
K516 Sumoylation
K516 Ubiquitination
K527 Ubiquitination
K586 Ubiquitination
K644 Ubiquitination
T647 Phosphorylation
T648 Phosphorylation
Y668 Phosphorylation
K675 Ubiquitination
K681 Ubiquitination
Y682 Phosphorylation
Y683 Phosphorylation
K689 Ubiquitination
Y694 Phosphorylation Q06187 (BTK) , P12931 (SRC) , P52333 (JAK3) , P06239 (LCK) , P06213 (INSR) , P07948 (LYN) , P43405 (SYK) , Q13882 (PTK6) , O60674 (JAK2) , P08631 (HCK)
K696 Acetylation
K696 Sumoylation
K696 Ubiquitination
K700 Acetylation
Y720 Phosphorylation
S726 Phosphorylation
T757 Phosphorylation
S774 Phosphorylation
S777 Phosphorylation
S780 Phosphorylation Q13153 (PAK1) , P28482 (MAPK1) , P27361 (MAPK3)
S792 Phosphorylation
S794 Phosphorylation
Site PTM Type Enzyme
K56 Sumoylation
K70 Ubiquitination
K71 Ubiquitination
K84 Acetylation
K84 Ubiquitination
K86 Ubiquitination
Y90 Phosphorylation
T92 Phosphorylation
Y98 Phosphorylation
Y114 Phosphorylation
S127 Phosphorylation
S128 Phosphorylation
S132 Phosphorylation
K140 Ubiquitination
K163 Ubiquitination
K164 Ubiquitination
S193 Phosphorylation
K207 Ubiquitination
K232 Ubiquitination
K235 Ubiquitination
K242 Ubiquitination
T245 Phosphorylation
K256 Sumoylation
K256 Ubiquitination
K336 Sumoylation
K343 Ubiquitination
K359 Ubiquitination
K370 Ubiquitination
T372 Phosphorylation
S375 Phosphorylation
K380 Ubiquitination
K384 Acetylation
K384 Sumoylation
K384 Ubiquitination
Y392 Phosphorylation
K516 Sumoylation
K516 Ubiquitination
K527 Ubiquitination
K583 Ubiquitination
K586 Ubiquitination
S655 Phosphorylation
Y665 Phosphorylation
Y668 Phosphorylation
K675 Sumoylation
K675 Ubiquitination
Y679 Phosphorylation P12931 (SRC)
K681 Acetylation
K681 Ubiquitination
Y682 Phosphorylation
Y683 Phosphorylation
T684 Phosphorylation
C688 S-Nitrosylation
T692 Phosphorylation
K694 Acetylation
K694 Ubiquitination
Y699 Phosphorylation Q13882 (PTK6) , P06213 (INSR) , P08631 (HCK) , P12931 (SRC) , P00533 (EGFR) , O60674 (JAK2)
K701 Acetylation
K701 Sumoylation
K701 Ubiquitination
K705 Acetylation
Y725 Phosphorylation P00533 (EGFR)
S731 Phosphorylation
Y740 Phosphorylation P00533 (EGFR)
Y743 Phosphorylation P00533 (EGFR)
S787 Phosphorylation

Research Backgrounds

Function:

Carries out a dual function: signal transduction and activation of transcription. Mediates cellular responses to the cytokine KITLG/SCF and other growth factors. Mediates cellular responses to ERBB4. May mediate cellular responses to activated FGFR1, FGFR2, FGFR3 and FGFR4. Binds to the GAS element and activates PRL-induced transcription. Regulates the expression of milk proteins during lactation.

PTMs:

Tyrosine phosphorylated in response to KITLG/SCF, IL2, IL3, IL7, IL15, CSF2/GMCSF, GH1, PRL, EPO and THPO (By similarity). Activated KIT promotes phosphorylation on tyrosine residues and subsequent translocation to the nucleus. Tyrosine phosphorylated in response to constitutively activated FGFR1, FGFR2, FGFR3 and FGFR4 (By similarity). Tyrosine phosphorylation is required for DNA-binding activity and dimerization. Serine phosphorylation is also required for maximal transcriptional activity (By similarity). Tyrosine phosphorylated in response to signaling via activated FLT3; wild-type FLT3 results in much weaker phosphorylation than constitutively activated mutant FLT3. Alternatively, can be phosphorylated by JAK2 at Tyr-694.

ISGylated.

Subcellular Location:

Cytoplasm. Nucleus.
Note: Translocated into the nucleus in response to phosphorylation.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
Subunit Structure:

Forms a homodimer or a heterodimer with a related family member. Binds NR3C1 (By similarity). Interacts with NCOA1 and SOCS7. Interacts with ERBB4.

Family&Domains:

Belongs to the transcription factor STAT family.

Function:

Carries out a dual function: signal transduction and activation of transcription. Mediates cellular responses to the cytokine KITLG/SCF and other growth factors. Binds to the GAS element and activates PRL-induced transcription. Positively regulates hematopoietic/erythroid differentiation.

PTMs:

Tyrosine phosphorylated in response to signaling via activated KIT, resulting in translocation to the nucleus. Tyrosine phosphorylated in response to signaling via activated FLT3; wild-type FLT3 results in much weaker phosphorylation than constitutively activated mutant FLT3. Alternatively, can be phosphorylated by JAK2. Phosphorylation at Tyr-699 by PTK6 or HCK leads to an increase of its transcriptional activity.

Subcellular Location:

Cytoplasm. Nucleus.
Note: Translocated into the nucleus in response to phosphorylation.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
Subunit Structure:

Forms a homodimer or a heterodimer with a related family member. Binds NR3C1 (By similarity). Interacts with NCOA1. Interacts with NMI. Interacts with SOCS7. Interacts (via SH2 domain) with INSR. Interacts with CPEB3; this inhibits STAT5B-mediated transcriptional activation.

Family&Domains:

Belongs to the transcription factor STAT family.

Research Fields

· Cellular Processes > Cell growth and death > Necroptosis.   (View pathway)

· Environmental Information Processing > Signal transduction > ErbB signaling pathway.   (View pathway)

· Environmental Information Processing > Signal transduction > Jak-STAT signaling pathway.   (View pathway)

· Human Diseases > Infectious diseases: Viral > Hepatitis B.

· Human Diseases > Infectious diseases: Viral > Measles.

· Human Diseases > Infectious diseases: Viral > HTLV-I infection.

· Human Diseases > Cancers: Overview > Pathways in cancer.   (View pathway)

· Human Diseases > Cancers: Overview > Viral carcinogenesis.

· Human Diseases > Cancers: Specific types > Chronic myeloid leukemia.   (View pathway)

· Human Diseases > Cancers: Specific types > Acute myeloid leukemia.   (View pathway)

· Human Diseases > Cancers: Specific types > Non-small cell lung cancer.   (View pathway)

· Organismal Systems > Immune system > Chemokine signaling pathway.   (View pathway)

· Organismal Systems > Immune system > Th1 and Th2 cell differentiation.   (View pathway)

· Organismal Systems > Immune system > Th17 cell differentiation.   (View pathway)

· Organismal Systems > Endocrine system > Prolactin signaling pathway.   (View pathway)

Restrictive clause

 

Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.

For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.